image
Healthcare - Medical - Healthcare Plans - NYSE - US
$ 12.54
-3.54 %
$ 2.7 B
Market Cap
125.4
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one OSCR stock under the worst case scenario is HIDDEN Compared to the current market price of 12.5 USD, Oscar Health, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one OSCR stock under the base case scenario is HIDDEN Compared to the current market price of 12.5 USD, Oscar Health, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one OSCR stock under the best case scenario is HIDDEN Compared to the current market price of 12.5 USD, Oscar Health, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart OSCR

image
$19.0$19.0$18.0$18.0$17.0$17.0$16.0$16.0$15.0$15.0$14.0$14.0$13.0$13.0$12.0$12.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
9.18 B REVENUE
56.54%
57.3 M OPERATING INCOME
124.30%
26.1 M NET INCOME
109.65%
978 M OPERATING CASH FLOW
459.42%
-1.39 B INVESTING CASH FLOW
-240.38%
68.4 M FINANCING CASH FLOW
960.94%
2.39 B REVENUE
-1.28%
-148 M OPERATING INCOME
-205.39%
-153 M NET INCOME
-182.98%
347 M OPERATING CASH FLOW
169.34%
-31.4 M INVESTING CASH FLOW
94.56%
3.82 M FINANCING CASH FLOW
-79.43%
Balance Sheet Oscar Health, Inc.
image
Current Assets 2.85 B
Cash & Short-Term Investments 2.15 B
Receivables 316 M
Other Current Assets 378 M
Non-Current Assets 2 B
Long-Term Investments 1.82 B
PP&E 66.8 M
Other Non-Current Assets 113 M
44.45 %6.53 %7.80 %37.50 %Total Assets$4.8b
Current Liabilities 3.46 B
Accounts Payable 1.4 B
Short-Term Debt 0
Other Current Liabilities 2.07 B
Non-Current Liabilities 361 M
Long-Term Debt 300 M
Other Non-Current Liabilities 61.3 M
36.56 %54.00 %7.83 %Total Liabilities$3.8b
EFFICIENCY
Earnings Waterfall Oscar Health, Inc.
image
Revenue 9.18 B
Cost Of Revenue 0
Gross Profit 9.18 B
Operating Expenses 9.12 B
Operating Income 57.3 M
Other Expenses 31.1 M
Net Income 26.1 M
10b10b9b9b8b8b7b7b6b6b5b5b4b4b3b3b2b2b1b1b009b09b(9b)57m(31m)26mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
100.00% GROSS MARGIN
100.00%
0.62% OPERATING MARGIN
0.62%
0.28% NET MARGIN
0.28%
2.51% ROE
2.51%
0.53% ROA
0.53%
3.25% ROIC
3.25%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Oscar Health, Inc.
image
1b1b800m800m600m600m400m400m200m200m00(200m)(200m)(400m)(400m)202020202021202120222022202320232024202420252025
Net Income 26.1 M
Depreciation & Amortization 32.1 M
Capital Expenditures -27.9 M
Stock-Based Compensation 110 M
Change in Working Capital 839 M
Others 660 M
Free Cash Flow 950 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Oscar Health, Inc.
image
Wall Street analysts predict an average 1-year price target for OSCR of $25.2 , with forecasts ranging from a low of $21 to a high of $28 .
OSCR Lowest Price Target Wall Street Target
21 USD 67.46%
OSCR Average Price Target Wall Street Target
25.2 USD 101.36%
OSCR Highest Price Target Wall Street Target
28 USD 123.29%
Price
Max Price Target
Min Price Target
Average Price Target
282826262424222220201818161614141212May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 8
6. Ownership
Insider Ownership Oscar Health, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
3.09 M USD 7
6-9 MONTHS
7.61 M USD 6
9-12 MONTHS
2.89 M USD 6
Bought
0 USD 0
0-3 MONTHS
46.1 M USD 2
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Oscar Health, Inc. (OSCR) Increases Despite Market Slip: Here's What You Need to Know In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $13.61, indicating a +1.8% shift from the previous trading day. zacks.com - 2 weeks ago
Why Oscar Health, Inc. (OSCR) Outpaced the Stock Market Today In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $14.19, denoting a +1.65% change from the preceding trading day. zacks.com - 3 weeks ago
Is Trending Stock Oscar Health, Inc. (OSCR) a Buy Now? Oscar Health (OSCR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. zacks.com - 4 weeks ago
Oscar Health, Inc. (OSCR) Advances But Underperforms Market: Key Facts The latest trading day saw Oscar Health, Inc. (OSCR) settling at $12.85, representing a +0.16% change from its previous close. zacks.com - 1 month ago
Oscar Health, Inc. (OSCR) Laps the Stock Market: Here's Why Oscar Health, Inc. (OSCR) reachead $13.45 at the closing of the latest trading day, reflecting a +1.74% change compared to its last close. zacks.com - 1 month ago
Here's how Oscar Health CEO Mark Bertolini wants to fix the health insurance system Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, discusses potential solutions to some of the problems in the health insurance industry and why he believes the individual insurance market is the solution for Americans. youtube.com - 1 month ago
Oscar Health CEO on fixing the health insurance system: Individual insurance market is the solution Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, joins 'Squawk Box' to discuss potential solutions to some of the problems in the health insurance industry, why he believes the individual insurance market is the solution for Americans, and more. youtube.com - 1 month ago
Oscar Health: The Most Undervalued Small Cap But With One Big Risk I am bullish on Oscar Health (OSCR) due to its efficient D2C model, AI integration, and improving EBITDA margins despite high revenue growth. OSCR's opportunity in the ICHRA market is significant, with projections to increase 3x-5x by 2030, positioning it well against larger competitors. Risks include potential changes to ACA subsidies under future administrations, which could disrupt OSCR's current business model and force a shift to ICHRA. seekingalpha.com - 1 month ago
Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A NEW YORK--(BUSINESS WIRE)--Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX Ventures with participation from Floating Point, Thiel Bio, Founders Fund, Bertelsmann Investments, and existing investors, Giant Ventures and Obvious Ventures. The round also received backing from angel investors and healthcare pioneers, including Mario Schlosser, co-founder and former CEO of Oscar Health (NYSE: OSCR), Ryan Fukushima, COO of Tempus,. businesswire.com - 1 month ago
Oscar Health, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - OSCR NEW YORK, NY / ACCESS Newswire / March 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oscar Health, Inc. ("Oscar Health, Inc.") (NYSE:OSCR) concerning possible violations of federal securities laws. Oscar Health reported mixed earnings performance for the fourth quarter including a greater than expected loss of $0.62 per share. accessnewswire.com - 1 month ago
Oscar Health, Inc. (OSCR) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates NEW YORK, NY / ACCESS Newswire / March 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oscar Health, Inc. ("Oscar Health, Inc.") (NYSE:OSCR) concerning possible violations of federal securities laws. Oscar Health reported mixed earnings performance for the fourth quarter including a greater than expected loss of $0.62 per share. accessnewswire.com - 1 month ago
ATTENTION Oscar Health, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights NEW YORK, NY / ACCESS Newswire / February 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oscar Health, Inc. ("Oscar Health, Inc.") (NYSE:OSCR) concerning possible violations of federal securities laws. Oscar Health reported mixed earnings performance for the fourth quarter including a greater than expected loss of $0.62 per share. accessnewswire.com - 1 month ago
8. Profile Summary

Oscar Health, Inc. OSCR

image
COUNTRY US
INDUSTRY Medical - Healthcare Plans
MARKET CAP $ 2.7 B
Dividend Yield 0.00%
Description Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Contact 75 Varick Street, New York, NY, 10013 https://www.hioscar.com
IPO Date March 3, 2021
Employees 2400
Officers Adam McAnaney EVice President & Chief Legal Officer Dr. Okiki Louis President of Oscar Medical Group Mr. Joel I. Klein J.D. Senior Advisor Ms. Rebecca Krouse Chief People Officer Mr. Mark Thomas Bertolini Chief Executive Officer & Director Mr. Mario Tobias Schlosser Co-Founder, Chief Technology Officer & Director Ms. Ranmali Bopitiya Executive Vice President of Public Affairs Mr. Joshua Kushner Co-Founder & Vice Chairman Ms. Victoria Baltrus Chief Accounting Officer Chris Potochar Vice President of Treasury & Investor Relations